Smoking in schizophrenia: recent findings about an old problem

Area of Science:

• Psychiatry and Behavioral Sciences
• Neuroscience
• Genetics

Background:

• Schizophrenia is a complex mental disorder associated with high rates of cigarette smoking.
• Nicotine dependence in schizophrenia patients presents significant challenges to treatment and patient well-being.
• Previous research on smoking's effects on cognitive function in schizophrenia has yielded conflicting results.

Purpose of the Study:

• To review recent epidemiological, biological, and clinical findings on the correlation between high cigarette consumption and schizophrenia.
• To examine the impact of smoking on treatment strategies and antipsychotic effectiveness in schizophrenia patients.
• To clarify the intricate relationship between schizophrenia pathology and the neurobiological effects of nicotine.

Main Methods:

• Review of recent epidemiological data on smoking prevalence in schizophrenia.
• Analysis of biological and molecular studies investigating genetic links between smoking and schizophrenia.
• Evaluation of clinical findings on the association between smoking, symptom severity, and suicidal behavior.

Main Results:

• Despite global efforts, smoking rates remain high among individuals with schizophrenia.
• Smoking is associated with positive symptoms and suicidal behavior, and may increase the risk of developing schizophrenia.
• Smoking's previously suggested beneficial effects on cognitive dysfunction were not confirmed; instead, it may exacerbate symptoms and impede treatment.

Conclusions:

• Cigarette smoking adversely affects the health of individuals with schizophrenia and can influence symptom severity.
• The concept of 'self-medication by nicotine' is challenged by emerging evidence of harm.
• Cessation of smoking is strongly advocated, with a shift towards safer and more effective therapeutic interventions.